Delivery Order SPE2DR25D1100-SPE2DR26FCL4B
- Not listed
- The Defense Logistics Agency awarded a $1,799.82 delivery order to AmerisourceBergen Drug Corp for 180 tablets of Janumet 50-1,000 mg on September 15, 2025, with completion scheduled for September 16, 2025. This firm fixed-price contract, issued without set-aside designation, represents a competitively awarded delivery order leveraging AmerisourceBergen's existing indefinite delivery contract vehicle with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's...
- The Defense Logistics Agency awarded a delivery order valued at $1,448.64 to AmerisourceBergen Drug Corp for 180 tablets of Janumet 50-1,000 mg on April 21, 2025, with an ultimate completion date of April 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $6,160.10 to AmerisourceBergen Drug Corp for 180 tablets of Janumet 50-1,000 mg, a combination medication used to treat type 2 diabetes. This firm fixed-price delivery order, awarded on September 4, 2025, represents a non-competitive set-aside award and is expected to be completed by September 5, 2025. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp, the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, on September 8, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units) with a ceiling value of $3,223.51. This competitively awarded, firm fixed-price delivery order carries an ultimate completion date of September 9, 2025, and is being performed at the contractor's Conshohocken facility. No set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, the prime contractor, for the supply of Janumet 50-1,000 mg tablets (1,000 count) with a ceiling value of $60,770.17. The award, announced on October 29, 2025, with an ultimate completion date of October 30, 2025, was made on a firm fixed-price basis without a set-aside designation, indicating open and competitive procurement. The contract is being performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Janumet 50-1,000 mg tablets in quantities of 1,000 units, with a ceiling value of $2,012.06. This is a firm fixed price delivery order with an ultimate completion date of August 12, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units) under a firm fixed-price contract valued at $13,839.99. The delivery order is non-set-aside and competitively awarded, with an ultimate completion date of August 21, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units) with a ceiling value of $10,920.04. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for completion by September 11, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $9,376.56 to AmerisourceBergen Drug Corp for the supply of Janumet 50-1,000 mg tablets (60-count units) on July 24, 2025, with an ultimate completion date of July 25, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a delivery order valued at $7,622.60 to AmerisourceBergen Drug Corp for the supply of Janumet 50-1,000 mg tablets (180-count units) on September 25, 2025, with an ultimate completion date of September 26, 2025. This competitive, non-set-aside award is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania, under a firm fixed-price delivery order contract type. This delivery order is issued under AmerisourceBergen Drug Corp's...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCL4BDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,997.22 to AmerisourceBergen Drug Corp for 180 tablets of Janumet 50-1,000 mg on October 29, 2025, with completion scheduled for October 30, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. Janumet is a combination antidiabetic medication used in the management of type 2 diabetes, reflecting the Defense Logistics Agency's ongoing pharmaceutical procurement requirements for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion prime contract vehicle designated SPE2DX and extending through December 2026. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp supplies a comprehensive range of medications and medical supplies to support federal healthcare programs globally. The company's federal contracting history demonstrates consistent capability in fulfilling competitively awarded pharmaceutical orders across multiple therapeutic domains, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its flexible contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.0k | 10/29/25 |